Three-Helix Bundle Protein Ligands for Alkali-Stable Affinity Purification
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current affinity chromatography methods face challenges in efficiently purifying biologically produced therapeutics to high purity, particularly due to resource-intensive and time-consuming development of affinity ligands, and the need for ligands that are stable across bioprocessing conditions, such as those involving NaOH, as well as the scarcity of ligands effective for diverse biological macromolecules beyond IgG.
Innovation Solution
Development of nucleic acid and polypeptide libraries encoding three-helix bundle protein domains that can serve as high-affinity, alkali-stable ligands for various target molecules, including those not bound by IgG, using specific amino acid sequences and peptide tags for enhanced stability and versatility.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If traditional affinity ligands are used for purification, then high binding affinity can be achieved, but the development process becomes resource intensive and time consuming
Solution Approach 1:
The patent employs phage display technology to systematically vary and screen ligand sequences, enabling rapid identification of high-affinity binders through iterative mutation and selection processes. This allows exploration of sequence space to optimize binding parameters without traditional time-consuming development approaches.
Solution Approach 2:
The invention uses phage display to create and screen large libraries of copied and mutated ligand sequences displayed on phage surfaces. This copying approach allows parallel evaluation of numerous variants to identify optimal binders, dramatically accelerating the development process compared to traditional methods.
2Stability of the object's composition
If affinity ligands are designed for high stability under bioprocessing conditions, then ligand durability improves, but the scope of applicable target molecules decreases
Solution Approach 1:
The patent develops a universal three-helix bundle scaffold that can be adapted to bind multiple different target molecules including IgG, AAV, and other biologics. The conserved structural framework provides stability under bioprocessing conditions while the variable regions enable versatility across different target types.
Solution Approach 2:
The ligand is divided into stable structural core elements (three-helix bundle framework) and variable binding regions (complementarity determining regions). This segmentation allows the stable scaffold to provide durability under harsh conditions while the variable regions can be optimized for specific target molecules, achieving both stability and versatility.
3Adaptability or versatility
If diverse ligand architectures are explored to bind different biological macromolecules, then target coverage increases, but the complexity of library screening increases
Solution Approach 1:
The patent employs a universal three-helix bundle scaffold that serves as a platform for generating ligands against multiple different target molecules. This single scaffold architecture can be adapted through variable region modification to bind IgG, AAV, and other biologics, simplifying the overall approach compared to maintaining multiple specialized ligand systems.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
These libraries enable the rapid identification and isolation of high-affinity ligands that can withstand harsh bioprocessing conditions, facilitating efficient purification of diverse biological molecules and reducing the economic and temporal burdens of ligand development.
Implementation Method 1
the need for having many different libraries remains. For example, in one study, 48 different scaffold families were interrogated for ligand discovery, and the 62 best ligands were all drawn from a single scaffold library
Data Source
AI summary
The present disclosure relates to the field of affinity chromatography, and more specifically to the provision of nucleic acid and polypeptide libraries encoding three-helix bundle protein domains suitable for selecting affinity ligands that specifically binds to a target molecule of interest. The disclosure also relates to methods of using those libraries to identify and isolate such affinity ligands to a target molecule.